Canopy Growth: When Dilution Disguises Desperation

Canopy Growth’s capital raises via warrant issuances continue a troubling pattern: the company dilutes existing shareholders to fund acquisitions that have failed to generate returns. Investors…

Sanity Group Synergies: Where the Real Value Hides

Organigram’s €227M commitment to Sanity Group assumes meaningful synergies on the back end. Analysis of Sanity’s German operations reveals cost consolidation opportunities, but regulatory and…

Curaleaf’s Cash Runway: The 18-Month Countdown

Curaleaf Holdings’ \$500M loan comes with a ticking clock. At current cash burn rates, the capital provides approximately 18-24 months of operational runway before the company faces a critical…

📅 Yesterday's News & Older Articles →